Cargando…
ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
A matrix therapy agent marketed as CACIPLIQ20(®) showed marked improvement in the healing rate of hand infections, including functional recovery. It can be used at both earlier and later stages to promote faster healing and prevent an adverse outcome.
Autores principales: | Roohi, Sharifah Ahmad, Keuylian, Zela, Barritault, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981774/ https://www.ncbi.nlm.nih.gov/pubmed/33768787 http://dx.doi.org/10.1002/ccr3.3645 |
Ejemplares similares
-
ReGeneraTing Agents (RGTA
(®)) are a new option to improve amputation outcomes in the recovery of severe hand injuries
por: Ahmad, Roohi Sharifah, et al.
Publicado: (2018) -
ReGeneraTing Agents (RGTA(®)): A new option for healing and improving treatment outcomes for traumatic and burn injuries of the hand
por: Roohi, Sharifah Ahmad, et al.
Publicado: (2019) -
RGTA(®) or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients
por: Barritault, Denis, et al.
Publicado: (2016) -
Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases
por: Sánchez-Ávila, Ronald M., et al.
Publicado: (2021) -
A Rapid Response to Matrix Therapy With RGTA in Severe Epidermolysis Bullosa
por: Malaq, Ali Al, et al.
Publicado: (2012)